Edwards Lifesciences (EW) Short Interest Ratio & Short Volume $78.07 -0.73 (-0.93%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$78.04 -0.03 (-0.04%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Edwards Lifesciences Short Interest DataEdwards Lifesciences (EW) has a short interest of 7.21 million shares, representing 1.25% of the float (the number of shares available for trading by the public). This marks a 18.78% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 5.26 million shares to cover all short positions.Current Short Interest7,210,000 sharesPrevious Short Interest6,070,000 sharesChange Vs. Previous Month+18.78%Dollar Volume Sold Short$564.83 millionShort Interest Ratio1.7 Days to CoverLast Record DateJune 30, 2025Outstanding Shares586,600,000 sharesFloat Size574,690,000 sharesShort Percent of Float1.25%Today's Trading Volume3,780,176 sharesAverage Trading Volume5,256,833 sharesToday's Volume Vs. Average72% Short Selling Edwards Lifesciences? Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEW Short Interest Over TimeEW Days to Cover Over TimeEW Percentage of Float Shorted Over Time Edwards Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20257,210,000 shares $564.83 million +18.8%1.3%1.7 $78.34 6/15/20256,070,000 shares $455.97 million +3.9%1.1%1.3 $75.12 5/31/20255,840,000 shares $456.05 million -20.9%1.0%1.2 $78.09 5/15/20257,380,000 shares $566.71 million -10.4%1.3%1.5 $76.79 4/30/20258,240,000 shares $622.12 million +3.9%1.4%1.8 $75.50 4/15/20257,930,000 shares $560.13 million -16.9%1.4%1.6 $70.63 3/31/20259,540,000 shares $692.25 million +1.0%1.7%2 $72.56 3/15/20259,450,000 shares $655.52 million +11.3%1.6%2 $69.37 2/28/20258,490,000 shares $607.97 million -28.7%1.5%1.8 $71.61 2/15/202511,900,000 shares $907.08 million +18.4%2.1%2.5 $76.23 Get the Latest News and Ratings for EW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202510,050,000 shares $727.69 million +11.2%1.7%2.1 $72.41 1/15/20259,040,000 shares $635.42 million -20.1%1.6%1.8 $70.29 12/31/202411,310,000 shares $837.28 million +54.9%2.0%2.2 $74.03 12/15/20247,300,000 shares $535.24 million -14.9%1.3%1.3 $73.32 11/30/20248,580,000 shares $612.18 million +24.9%1.5%1.5 $71.35 11/15/20246,870,000 shares $465.51 million -10.8%1.2%1.1 $67.76 10/31/20247,700,000 shares $516.05 million -6.3%1.3%1.3 $67.02 10/15/20248,220,000 shares $566.36 million -14.5%1.4%1.2 $68.90 9/30/20249,610,000 shares $634.16 million -15.6%1.6%1.4 $65.99 9/15/202411,380,000 shares $779.76 million +81.8%1.9%1.8 $68.52 8/31/20246,260,000 shares $437.95 million -1.3%1.1%1.1 $69.96 8/15/20246,340,000 shares $432.01 million +3.9%1.1%1.3 $68.14 7/31/20246,100,000 shares $384.54 million -20.8%1.0%1.4 $63.04 7/15/20247,700,000 shares $689.15 million -15.8%1.3%2.7 $89.50 6/30/20249,140,000 shares $844.26 million +11.6%1.5%3.3 $92.37 6/15/20248,190,000 shares $714.91 million -1.2%1.4%3 $87.29 5/31/20248,290,000 shares $720.94 million +3.6%1.4%2.9 $86.97 5/15/20248,000,000 shares $721.28 million -16.9%1.4%2.5 $90.16 4/30/20249,630,000 shares $815.47 million +30.5%1.6%2.7 $84.68 4/15/20247,380,000 shares $658.30 million -28.9%1.3%1.9 $89.20 3/31/202410,380,000 shares $991.91 million -0.7%1.8%2.6 $95.56 3/15/202410,450,000 shares $964.64 million +23.8%1.8%2.7 $92.31 2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87 2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06 1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47 1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03 12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25 12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90 11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71 11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad)Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.Get the name of Buffett’s likely gold target here 10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72 10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78 9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28 9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20 8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47 8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86 7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07 7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38 6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33 6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29 5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24 5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92 4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98 4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36 3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73 3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48 2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44 2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92 1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70 1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31 12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61 12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55 11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25 11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96 10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43 10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42 9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63 9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88 8/31/20223,680,000 shares $331.57 million -27.0%0.6%1.4 $90.10 8/15/20225,040,000 shares $527.89 million -9.0%0.8%2 $104.74 7/31/20225,540,000 shares $556.99 million -16.8%0.9%2.1 $100.54 7/15/20226,660,000 shares $662.20 million +7.3%1.1%2.4 $99.43 6/30/20226,210,000 shares $590.51 million +5.8%1.0%2.2 $95.09 6/15/20225,870,000 shares $521.14 million -10.5%2.9%2 $88.78 5/31/20226,560,000 shares $661.58 million +27.4%1.1%2.3 $100.85 5/15/20225,150,000 shares $502.38 million +6.0%0.8%1.9 $97.55 4/30/20224,860,000 shares $514.09 million -15.2%0.8%1.8 $105.78 4/15/20225,730,000 shares $687.71 million +28.5%0.9%2.1 $120.02 3/31/20224,460,000 shares $525.03 million No Change0.7%1.7 $117.72 3/15/20224,460,000 shares $473.43 million -20.6%0.7%1.7 $106.15 2/28/20225,620,000 shares $631.52 million -11.1%0.9%2.1 $112.37 2/15/20226,320,000 shares $701.08 million +9.5%1.0%2.3 $110.93 1/31/20225,770,000 shares $630.08 million +6.5%0.9%2.2 $109.20 1/15/20225,420,000 shares $640.97 million -10.9%0.9%2.2 $118.26 12/31/20216,080,000 shares $787.66 million +10.0%1.0%2.6 $129.55 12/15/20215,530,000 shares $663.10 million -3.8%0.9%2.2 $119.91 11/30/20215,750,000 shares $617.03 million +4.0%0.9%2.5 $107.31 11/15/20215,530,000 shares $645.30 million -20.2%0.9%2.6 $116.69 10/29/20216,930,000 shares $830.35 million +6.0%1.1%3.3 $119.82 10/15/20216,540,000 shares $733.53 million +7.6%1.1%3.2 $112.16Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad)Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.Get the name of Buffett’s likely gold target here 9/30/20216,080,000 shares $688.32 million +2.7%1.0%2.8 $113.21 9/15/20215,920,000 shares $716.44 million -2.0%1.0%2.8 $121.02 8/31/20216,040,000 shares $707.77 million +0.8%1.0%2.8 $117.18 8/13/20215,990,000 shares $677.77 million -1.3%1.0%2.6 $113.15 7/30/20216,070,000 shares $681.48 million -8.9%1.0%2.6 $112.27 7/15/20216,660,000 shares $708.22 million +20.4%1.1%2.8 $106.34 6/30/20215,530,000 shares $572.74 million -9.1%0.9%2.2 $103.57 6/15/20216,080,000 shares $609.70 million +4.5%1.0%2.4 $100.28 5/28/20215,820,000 shares $558.14 million -2.8%0.9%2.3 $95.90 5/14/20215,990,000 shares $526.76 million -13.4%N/A2.2 $87.94 4/30/20216,920,000 shares $666.12 million +5.2%N/A2.5 $96.26 4/15/20216,580,000 shares $567.53 million +24.6%N/A2.3 $86.25 3/31/20215,280,000 shares $437.45 million -2.6%N/A2 $82.85 3/15/20215,420,000 shares $444.82 million -3.0%N/A2.1 $82.07 2/26/20215,590,000 shares $469.39 million -17.1%N/A2.2 $83.97 2/12/20216,740,000 shares $593.59 million +50.8%N/A2.8 $88.07 1/29/20214,470,000 shares $372.71 million +3.5%N/A1.8 $83.38 1/15/20214,320,000 shares $377.96 million -6.9%N/A1.7 $87.49 12/31/20204,640,000 shares $415.93 million -5.7%N/A1.9 $89.64 12/15/20204,920,000 shares $411.16 million -7.5%N/A2 $83.57 11/30/20205,320,000 shares $453.58 million +6.0%N/A2.1 $85.26 11/15/20205,020,000 shares $410.54 million +0.8%N/A1.9 $81.78 10/30/20204,980,000 shares $363.09 million -29.7%N/A2 $72.91 10/15/20207,080,000 shares $603.00 million +5.8%N/A3 $85.17 9/30/20206,690,000 shares $534.00 million -2.8%N/A2.6 $79.82 9/15/20206,880,000 shares $573.10 million -5.0%N/A2.6 $83.30 8/31/20207,240,000 shares $621.48 million +15.7%N/A2.7 $85.84 8/14/20206,260,000 shares $488.72 million -3.4%N/A2.2 $78.07 7/31/20206,480,000 shares $508.10 million -12.0%N/A2.2 $78.41 7/15/20207,360,000 shares $524.18 million -7.1%N/A2.3 $71.22 EW Short Interest - Frequently Asked Questions What is Edwards Lifesciences' current short interest? Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 7,210,000 shares of EW short. 1.25% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest. What is a good short interest ratio for Edwards Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 2.0. Learn More on Edwards Lifesciences's short interest ratio. Which institutional investors are shorting Edwards Lifesciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: Baader Bank Aktiengesellschaft, Quaker Wealth Management LLC, Jane Street Group LLC, Goldman Sachs Group Inc., Millennium Management LLC, TIG Advisors LLC, Cubist Systematic Strategies LLC, Caption Management LLC, Twin Tree Management LP, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Hsbc Holdings PLC, Simplex Trading LLC, JPMorgan Chase & Co., Citigroup Inc., Baader Bank Aktiengesellschaft, Cetera Investment Advisers, Allianz Asset Management GmbH, Caas Capital Management LP, and Fulcrum Asset Management LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Edwards Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.25% of Edwards Lifesciences' floating shares are currently sold short. Is Edwards Lifesciences' short interest increasing or decreasing? Edwards Lifesciences saw a increase in short interest in June. As of June 30th, there was short interest totaling 7,210,000 shares, an increase of 18.8% from the previous total of 6,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edwards Lifesciences' float size? Edwards Lifesciences currently has issued a total of 586,600,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 574,690,000 shares. How does Edwards Lifesciences' short interest compare to its competitors? 1.25% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edwards Lifesciences: Henry Schein, Inc. (6.90%), AMN Healthcare Services Inc (11.48%), Boston Scientific Corporation (1.29%), Stryker Corporation (1.61%), Medtronic PLC (0.94%), Becton, Dickinson and Company (1.36%), IDEXX Laboratories, Inc. (3.20%), ResMed Inc. (6.96%), DexCom, Inc. (2.69%), STERIS plc (0.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Edwards Lifesciences stock? Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading down $0.73 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edwards Lifesciences? A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further. How often is Edwards Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies HSIC Short Squeeze AMN Short Squeeze BSX Short Squeeze SYK Short Squeeze MDT Short Squeeze BDX Short Squeeze IDXX Short Squeeze RMD Short Squeeze DXCM Short Squeeze STE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EW) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
